Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) EBT: 2022-2024

Historic EBT for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$98.3 million.

  • Lexeo Therapeutics' EBT rose 2.68% to -$14.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$66.4 million, marking a year-over-year change of. This contributed to the annual value of -$98.3 million for FY2024, which is 48.11% down from last year.
  • Lexeo Therapeutics' EBT amounted to -$98.3 million in FY2024, which was down 48.11% from -$66.4 million recorded in FY2023.
  • In the past 5 years, Lexeo Therapeutics' EBT ranged from a high of -$59.3 million in FY2022 and a low of -$98.3 million during FY2024.
  • Over the past 3 years, Lexeo Therapeutics' median EBT value was -$66.4 million (recorded in 2023), while the average stood at -$74.7 million.
  • Data for Lexeo Therapeutics' EBT shows a maximum YoY crashed of 48.11% (in 2024) over the last 5 years.
  • Lexeo Therapeutics' EBT (Yearly) stood at -$59.3 million in 2022, then fell by 12.01% to -$66.4 million in 2023, then plummeted by 48.11% to -$98.3 million in 2024.